INCRESYNC 25/30mg 28tab

INCRESYNC 25/30 mg Tablets – 28 Tablets Active Ingredients: Sitagliptin 25 mg / Metformin 30 mg Therapeutic Class: Oral Antidiabetic – DPP-4 Inhibitor + BiguanideDescription: INCRESYNC combines sitagliptin, a DPP-4 inhibitor that enhances insulin secretion and lowers glucagon, with metformin, which decreases hepatic glucose production and improves insulin sensitivity. This combination is effective in managing type 2 diabetes.Indications: Treatment of type 2 diabetes in adults when diet, exercise, and monotherapy are insufficient. Can be used alone or with other antidiabetic agents. Dosage: Typically one tablet twice daily with meals. Dose adjusted according to blood glucose levels and patient tolerance. Contraindications: Type 1 diabetes Diabetic ketoacidosis Severe renal or hepatic impairment Hypersensitivity to sitagliptin, metformin, or excipients Warnings: Monitor kidney function regularly Risk of lactic acidosis (rare but serious) Caution in liver or heart disease Not recommended during pregnancy or breastfeeding Side Effects: Gastrointestinal discomfort Hypoglycemia (especially with insulin or sulfonylureas) Headache Storage: Store below 30°C in a dry place, away from sunlight.